Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?

Table 6 Selected cytokines and their correlations with cholesterol subfractions in MS patients after controlling for age, BMI and gender (*p < 0.05, **p < 0.01)

MS patients	IL-1β	IL-2	IL-4	IL-5	IL-6	IL-7	IL-8	IL-10	IL-12	IL-13	IL-17	G-CSF	GM-CSF	IFN-γ	TNF-α
VLDL (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	− 0.655 **	NS	NS
IDL-A (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	0.739 **	NS	NS
IDL-B (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	0.684 **	NS	NS
IDL-C (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS
LDL1 (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS
LDL2 (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS
LDL1–2 (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS
LDL3–7 (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS
L-HDL (mg/dl)	−0.600 *	−0.577 *	−0.579 *	−0.640 **	−0.711 **	−0.625 *	−0.691 **	−0.626 *	−0.649 **	−0.558 *	NS	−0.587 *	−0.685 **	−0.614 *	− 0.589 *
I-HDL (mg/dl)	NS	NS	NS	0.541 *	NS	NS	NS	NS	0.602 *	0.553 *	NS	NS	NS	NS	0.561 *
S-HDL (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS
Total HDL (mg/dl)	NS	NS	NS	NS	−0.589 *	NS	−0.564 *	−0.527 *	NS	NS	NS	−0.551 *	− 0.602 *	NS	NS
Total cholesterol (mg/dl)	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS	NS

ISSN: 1476-511X